High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia
W Du, J He, W Zhou, S Shu, J Li, W Liu, Y Deng… - Journal of translational …, 2019 - Springer
Background Elevated protein expressions of CD markers such as IL2RA/CD25,
CXCR4/CD184, CD34 and CD56 are associated with adverse prognosis in acute myeloid …
CXCR4/CD184, CD34 and CD56 are associated with adverse prognosis in acute myeloid …
[HTML][HTML] Clinical significance of CD200 and CD56 expression in patients with acute myeloid leukemia
S Aref, N Abousamara, E El-Helaly… - Asian Pacific Journal of …, 2020 - ncbi.nlm.nih.gov
Background: Acute myeloid leukemia (AML) escape from immunosurveillance by
immunosuppression. CD200 and CD56 expression represented an independent prognostic …
immunosuppression. CD200 and CD56 expression represented an independent prognostic …
High expression of CD56 may be associated with favorable overall survival in intermediate-risk acute myeloid leukemia
C Chen, CL Chio, H Zeng, Y Li - Hematology, 2021 - Taylor & Francis
ABSTRACT Objectives Previous study (Br. J. Haematol. 2017; 176: 498) reported that CD56
positive is associated with poor prognosis of patients with intermediate-risk acute myeloid …
positive is associated with poor prognosis of patients with intermediate-risk acute myeloid …
A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute …
J Song, W Li, Y Bai, P Zhou, J Niu, X Niu, Y Liu… - Annals of …, 2024 - Springer
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive myeloid
malignancy which characteristically expresses an atypical phenotype including CD123+ …
malignancy which characteristically expresses an atypical phenotype including CD123+ …
Adverse outcome of AML with aberrant CD16 and CD56 NK cell marker expression
A Junge, U Bacher, BU Mueller, P Keller… - Hematological …, 2018 - Wiley Online Library
Natural killer cells mediate antibody‐dependent cell‐mediated cytotoxicity, and CD16 exerts
key functions to induce antibody‐dependent cell‐mediated cytotoxicity response. Because …
key functions to induce antibody‐dependent cell‐mediated cytotoxicity response. Because …
[PDF][PDF] Expression of aberrant markers in acute leukemia at south Egypt cancer institute: A retrospective study
MA Mohamed, EA Shafik, AO Ahmed… - SECI Oncol, 2021 - secioj.journals.ekb.eg
Background: Aberrant phenotypes in acute leukemia (AL) have variable frequency and their
prognostic relevance is controversial and dissimilar results have been reported by different …
prognostic relevance is controversial and dissimilar results have been reported by different …
[HTML][HTML] Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia
MF Bezerra, JL Coelho-Silva, JC Nascimento… - …, 2017 - ncbi.nlm.nih.gov
In acute myeloid leukemia (AML), alterations involving the tumor suppressor gene TP53,
including mutations, deletions, or both, are frequently associated with older age and very …
including mutations, deletions, or both, are frequently associated with older age and very …
[图书][B] Lymph Node FNC: Cytopathology of Lymph Nodes and Extranodal Lymphoproliferative Processes
P Zeppa, I Cozzolino - 2017 - books.google.com
This well-illustrated monograph presents a comprehensive description of Fine-Needle
Cytology (FNC), including technical procedures and ancillary techniques, applied to the …
Cytology (FNC), including technical procedures and ancillary techniques, applied to the …
Blast counts are lower in the aspirate as compared to trephine biopsy in acute myeloid leukemia and myelodysplastic syndrome expressing CD56
B Drexler, A Tzankov, M Martinez… - International Journal …, 2021 - Wiley Online Library
Introduction CD56 is aberrantly expressed in myeloid neoplasms including myelodysplastic
syndrome (MDS) and acute myeloid leukemia (AML). Considering the adhesion effects of …
syndrome (MDS) and acute myeloid leukemia (AML). Considering the adhesion effects of …
Lymph Node Haematopoietic, Histiocytic, Dendritic Proliferations and Other Lymphoid Organs
P Zeppa, I Cozzolino - Lymph Node FNC, 2018 - karger.com
sent CD30 positivity and decreased MB2 (B-cell antigen) and CD45RO expression [1]. The
diagnosis of LNP by FNC relies on its cytological features and on immunocytochemistry …
diagnosis of LNP by FNC relies on its cytological features and on immunocytochemistry …